El Amir Y, Omar W, Khabrani A, Jahfali A, Alhakami S, Dobab N
J Adv Vet Anim Res. 2019; 6(4):521-527.
PMID: 31819881
PMC: 6882723.
DOI: 10.5455/javar.2019.f377.
McDuffie J, Chen Y, Ma J, Lee S, Lynch K, Hamlin D
Toxicol Res (Camb). 2018; 5(4):1202-1215.
PMID: 30090426
PMC: 6062370.
DOI: 10.1039/c5tx00497g.
Zhang P, Chen J, Huang W, Li W, Huang Y, Zhang Z
Sci Rep. 2017; 7:44804.
PMID: 28300186
PMC: 5353697.
DOI: 10.1038/srep44804.
Pedram B, Moghadam A, Kamyabi-Moghaddam Z, Mavedati O, Beigi B, Sharabiyani A
Tumour Biol. 2015; 36(6):4495-500.
PMID: 25596088
DOI: 10.1007/s13277-015-3091-1.
Parrish A, Chen G, Burghardt R, Watanabe T, Morisseau C, Hammock B
Cell Biol Toxicol. 2008; 25(3):217-25.
PMID: 18386137
PMC: 3033346.
DOI: 10.1007/s10565-008-9071-0.
Cisplatin and siRNA interference with structure and function of Wnt-5a mRNA: design and in vitro evaluation of targeting AU-rich elements in the 3' UTR.
Hagerlof M, Papsai P, Hedman H, Jungwirth U, Jenei V, Elmroth S
J Biol Inorg Chem. 2007; 13(3):385-99.
PMID: 18058140
DOI: 10.1007/s00775-007-0327-6.
Cardiotoxicity of cancer chemotherapy: implications for children.
Simbre V, Duffy S, Dadlani G, Miller T, Lipshultz S
Paediatr Drugs. 2005; 7(3):187-202.
PMID: 15977964
DOI: 10.2165/00148581-200507030-00005.
Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
Pai V, Nahata M
Drug Saf. 2000; 22(4):263-302.
PMID: 10789823
DOI: 10.2165/00002018-200022040-00002.
Methimazole as a protectant against cisplatin-induced nephrotoxicity using the dog as a model.
Vail D, Elfarra A, Cooley A, Panciera D, MacEwen E, Soergel S
Cancer Chemother Pharmacol. 1993; 33(1):25-30.
PMID: 8269585
DOI: 10.1007/BF00686018.
New cisplatin analogues in development. A review.
Weiss R, Christian M
Drugs. 1993; 46(3):360-377.
PMID: 7693428
DOI: 10.2165/00003495-199346030-00003.
Tissue organ distribution and behavioral effects of platinum following acute and repeated exposure of the mouse to platinum sulfate.
Lown B, Morganti J, Stineman C, DAgostino R, Massaro E
Environ Health Perspect. 1980; 34:203-12.
PMID: 7389684
PMC: 1568532.
DOI: 10.1289/ehp.8034203.
Effect of thymidine on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II).
Grossie Jr V, Valdivieso M, Drewinko B, Loo T
Cancer Chemother Pharmacol. 1984; 13(1):27-30.
PMID: 6539657
DOI: 10.1007/BF00401442.
The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat.
Graziano J, Jones B, Pisciotto P
Br J Pharmacol. 1981; 73(3):649-54.
PMID: 6265016
PMC: 2071699.
DOI: 10.1111/j.1476-5381.1981.tb16800.x.
Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide.
Heidemann H, Gerkens J, Jackson E, Branch R
Naunyn Schmiedebergs Arch Pharmacol. 1985; 329(2):201-5.
PMID: 4040218
DOI: 10.1007/BF00501213.
Combinations of single doses and fractionated treatments of cis-dichlorodiammineplatinum (II) and irradiation: effect on mouse lip mucosa.
Landuyt W, Ang K, van der Schueren E
Br J Cancer. 1986; 54(4):579-86.
PMID: 3778802
PMC: 2001496.
DOI: 10.1038/bjc.1986.212.
Pattern of toxicity by titanocene dichloride in mice. Blood and urine chemical parameters.
Gerlach S
J Cancer Res Clin Oncol. 1986; 111(3):243-7.
PMID: 3733855
DOI: 10.1007/BF00389240.
Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.
Bregman C, Williams P
Cancer Chemother Pharmacol. 1986; 18(2):117-23.
PMID: 3539384
DOI: 10.1007/BF00262279.
The effect of cisplatin on renal ATPase activity in vivo and in vitro.
Uozumi J, Litterst C
Cancer Chemother Pharmacol. 1985; 15(2):93-6.
PMID: 2990752
DOI: 10.1007/BF00257515.
Preclinical toxicity and pharmacology of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).
Perez-Soler R, Lautersztain J, Stephens L, Wright K, Khokhar A
Cancer Chemother Pharmacol. 1989; 24(1):1-8.
PMID: 2720887
DOI: 10.1007/BF00254097.
Cisplatin nephrotoxicity. A review.
Daugaard G, Abildgaard U
Cancer Chemother Pharmacol. 1989; 25(1):1-9.
PMID: 2686850
DOI: 10.1007/BF00694330.
